The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 100, Issue 5, 2015, Pages F448-F452

  Ng, Pak Cheung ^a   Ma, Terence Ping Yuen ^a   Lam, Hugh Simon ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN C2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD11B ANTIGEN; CD64 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN; PROCALCITONIN; PROTEIN S 100; RANTES; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BIOINFORMATICS; BLOOD SAMPLING; CLINICAL FEATURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; HEART RATE VARIABILITY; HUMAN; LABORATORY TEST; MECONIUM ASPIRATION; METABOLOMICS; METAGENOMICS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORTALITY; NEWBORN SEPSIS; POINT OF CARE TESTING; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TURNAROUND TIME; ENTEROCOLITIS, NECROTIZING; HOSPITAL INFORMATION SYSTEM; INFANT, PREMATURE, DISEASES; PREMATURITY; SEPSIS; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKERS; EARLY DIAGNOSIS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; POINT-OF-CARE SYSTEMS; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84946408059     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2014-307656     Document Type: Review

References (32)

1. Ng PC. Diagnostic markers of infection in neonate. Arch Dis Child Fetal Neonatal Ed 2004;89:F229-35.
2. Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997;77:221-7.
3. Lam HS, Cheung HM, Poon TCW, et al. Neutrophil CD64 for daily surveillance of systemic infection and necrotizing enterocolitis in preterm infants. Clin Chem 2013;59:1753-60.
4. Küster H, Weiss M, Willeitner AE, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998;352:1271-7.
5. Turunen R, Andersson S, Nupponen I, et al. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005;57:270-5.
6. Pourcyrous M, Korones SB, Yang W, et al. C-reactive protein in the diagnosis, management and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005;116:1064-9.
7. Ng PC, Li K, Leung TF, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006;52:1181-9.
8. Ng PC, Li K, Wong RPO, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
9. Ng EW, Poon TCW, Lam HS, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111-18.
10. Thuijls G, Derikx JP, van Wijck K, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174-80.
11. Fanos V, Caboni P, Corsello G, et al. Urinary (1) H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum Dev 2014;90:S78-83.
12. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013;62:1591-601.
13. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010;120:2989-3000.
14. Mai V, Young CM, Ukhanova M, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE 2011;6:e20647.
15. Ng PC, Li K, Wong RPO, et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002;51:296-303.
16. Josefsson S, Bunn SK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407-13.
17. Dabritz J, Jenke A, Wirth S, et al. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012;161:1059-64.
18. Fairchild KD, Schelonka RL, Kaufman DA, et al. Septicemia mortality reduction in neonates in a heart rate characteristics monitoring trial. Pediatr Res 2013;74:570-5.
19. Stone ML, Tatum PM, Weitkamp JH, et al. Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis. J Perinatol 2013;33:847-50.
20. Fairchild KD. Predictive monitoring for early detection of sepsis in neonatal ICU patients. Curr Opin Pediatr 2013;25:172-9.
21. Buchegger P, Sauer U, Toth-Székély H, et al. Miniaturized protein microarray with internal calibration as point-of-care device for diagnosis of neonatal sepsis. Sensors 2012;12:1494-508.
22. Batfalsky A, Lohr A, Heussen N, et al. Diagnostic value of an interleukin-6 bedside test in term and preterm neonates at the time of clinical suspicion of early-and late-onset bacterial infection. Neonatology 2012;102:37-44.
23. Zoppelli L, Guttel C, Bittrich HJ, et al. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology 2012;102:68-74.
24. Carroll D, Corfield A, Spicer R, et al. Faecal calprotectin concentrations and diagnosis of necrotizing enterocolitis. Lancet 2003;361:310-11.
25. Campeotto F, Baldassarre M, Butel MJ, et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009;48:507-10.
26. Evennett NJ, Hall NJ, Pierro A, et al. Urinary intestinial fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735-40.
27. Edelson MB, Sonnino RE, Bagwell CE, et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999;34:1453-7.
28. Aydemir C, Dilli D, Oguz SS, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011;87:659-61.
29. Sylvester KG, Ling XB, Liu GY, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr 2014;164:607-12.
30. Chan KY, Lam HS, Cheung HM, et al. Rapid identification and differentiation of gram-negative and gram-positive bacterial bloodstream infections by quantitative polymerase chain reaction in preterm infants. Crit Care Med 2009;37:2441-7.
31. Wu YD, Chen LH, Wu XJ, et al. Gram Stain-Specific-Probe-Based Real-Time PCR for diagnosis and discrimination of bacterial neonatal sepsis. J Clin Microbiol 2008;46:2613-19.
32. Kasper DC, Altiok I, Mechtler TP, et al. Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept. Neonatology 2013;103:268-73.